Literature DB >> 23363615

An examination of the mechanisms by which neural precursors augment recovery following spinal cord injury: a key role for remyelination.

Gregory W J Hawryluk1, Stefania Spano, Derek Chew, Shelly Wang, Mark Erwin, Mahmood Chamankhah, Nicole Forgione, Michael G Fehlings.   

Abstract

The mechanisms by which neural precursor cells (NPCs) enhance functional recovery from spinal cord injury (SCI) remain unclear. Spinal cord injured rats were transplanted with wild-type mouse NPCs, shiverer NPCs unable to produce myelin, dead NPCs, or media. Most animals also received minocycline, cyclosporine, and perilesional infusion of trophins. Motor function was graded according to the BBB scale. H&E/LFB staining was used to assess gray and white matter, cyst, and lesional tissue. Mature oligodendrocytes and ED1(+) inflammatory cells were quantitated. Confocal and electron microscopy were used to assess the relationship between the transplanted cells and axons. Pharmacotherapy and trophin infusion preserved gray matter, white matter, and oligodendrocytes. Trophin infusion also significantly increased cyst and lesional tissue volume as well as inflammatory infiltrate, and functional recovery was reduced. Animals transplanted with wild-type NPCs showed greatest functional recovery; animals transplanted with shiverer NPCs performed the worst. Wild-type NPCs remyelinated host axons. Shiverer NPCs ensheathed axons but did not produce MBP. These results suggest that remyelination by NPCs is an important contribution to functional recovery following SCI. Shiverer NPCs may prevent remyelination by endogenous cells capable of myelin formation. These findings suggest that remyelination is an important therapeutic target following SCI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23363615     DOI: 10.3727/096368912X662408

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  21 in total

Review 1.  Cell transplantation therapy for spinal cord injury.

Authors:  Peggy Assinck; Greg J Duncan; Brett J Hilton; Jason R Plemel; Wolfram Tetzlaff
Journal:  Nat Neurosci       Date:  2017-04-25       Impact factor: 24.884

2.  Transplantation of Induced Pluripotent Stem Cell-Derived Neural Stem Cells Mediate Functional Recovery Following Thoracic Spinal Cord Injury Through Remyelination of Axons.

Authors:  Ryan P Salewski; Robert A Mitchell; Lijun Li; Carl Shen; Maria Milekovskaia; Andras Nagy; Michael G Fehlings
Journal:  Stem Cells Transl Med       Date:  2015-05-15       Impact factor: 6.940

Review 3.  Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped?

Authors:  Nicole Pukos; Matthew T Goodus; Fatma R Sahinkaya; Dana M McTigue
Journal:  Glia       Date:  2019-08-24       Impact factor: 7.452

Review 4.  Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials?

Authors:  Scott A Myers; Andrew N Bankston; Darlene A Burke; Sujata Saraswat Ohri; Scott R Whittemore
Journal:  Exp Neurol       Date:  2016-04-13       Impact factor: 5.330

5.  Effects of adult neural precursor-derived myelination on axonal function in the perinatal congenitally dysmyelinated brain: optimizing time of intervention, developing accurate prediction models, and enhancing performance.

Authors:  Crystal A Ruff; Hui Ye; Jean M Legasto; Natasha A Stribbell; Jian Wang; Liang Zhang; Michael G Fehlings
Journal:  J Neurosci       Date:  2013-07-17       Impact factor: 6.167

6.  Neural precursor cell transplantation enhances functional recovery and reduces astrogliosis in bilateral compressive/contusive cervical spinal cord injury.

Authors:  Jared T Wilcox; Kajana Satkunendrarajah; Jeffrey A Zuccato; Farshad Nassiri; Michael G Fehlings
Journal:  Stem Cells Transl Med       Date:  2014-08-08       Impact factor: 6.940

Review 7.  Rodent Hypoxia-Ischemia Models for Cerebral Palsy Research: A Systematic Review.

Authors:  Prakasham Rumajogee; Tatiana Bregman; Steven P Miller; Jerome Y Yager; Michael G Fehlings
Journal:  Front Neurol       Date:  2016-04-25       Impact factor: 4.003

Review 8.  Cell therapy and delivery strategies for spinal cord injury.

Authors:  Bruna Dos S Ramalho; Fernanda M de Almeida; Ana M B Martinez
Journal:  Histol Histopathol       Date:  2021-06-10       Impact factor: 2.303

Review 9.  The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges.

Authors:  Mohamad Khazaei; Ahad M Siddiqui; Michael G Fehlings
Journal:  J Clin Med       Date:  2014-12-29       Impact factor: 4.241

Review 10.  Myelin damage and repair in pathologic CNS: challenges and prospects.

Authors:  Arsalan Alizadeh; Scott M Dyck; Soheila Karimi-Abdolrezaee
Journal:  Front Mol Neurosci       Date:  2015-07-27       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.